Introduction
Left heart disease, including Left Heart Failure (LHF) associated with ischemia and endotoxemia, has been widely studied. Many advances have been made in the understanding of left heart disease, including characterization of left ventricular anatomy and its response to acute cardiac events. Furthermore, functional studies of the left heart have provided a vast array of data for further understanding left heart disease. In spite of its importance, right heart disease, which is distinctly different from LHF, has not been studied with the same degree as other aspects of left heart disease and remains relatively poorly understood. The primary function of the Right Ventricle (RV) is to deliver deoxygenated blood to the lungs for gas exchange. The RV effectively serves as a reservoir for blood returning to the heart via the right atrium, thereby optimizing venous return and providing sustained low-pressure perfusion through the lungs. To this end, the RV ejects blood somewhat continuously from the right atria to the lungs. On the contrary, the Left Ventricle (LV) generates high pressure pulsatile flow through arterial vessels with low compliance. In LHF it is well accepted that the process of cardiac remodeling itself, regardless of the initial cardiac event, is, although compensatory at first, detrimental in the long run [1] . There is now convincing evidence that intervening in the process of remodeling importantly reduces morbidity and mortality in patients with LHF [2] [3] . Thus, initially, LV dilatation may be considered as a protective mechanism to maintain cardiac "pump" function. However, this phenomenon ultimately leads to alterations of global function of the LV and ultimately aggravates LHF. RHF is now being increasingly recognized as distinctly different from LHF [4] , and an important mediator of overall cardiovascular collapse. However, very little is known about i) the structural and functional evolution of RV dysfunction in RHF, ii) the determining molecular and cellular mechanisms, iii) the direct (not afterload reducing) interventions that could preserve RV function.
We postulate that the study of RV is very interesting and important to understand the cardiac remodeling mechanisms observed in RHF. Since there is still unexploited potential for therapies that directly target the RV, a better understanding of the complex molecular events that initiate and perpetuate the process of RV dilation would facilitate the development of more selective and efficient therapies. Studying RV dilation leading to RHF is therefore fundamental, and requires the evaluation of RV proteome as well as the integration of these findings into the overall disease context. Proteomic technology allows the examination of global alterations pattern in protein expression in the diseased heart, and can provide new insights into the cellular mechanisms involved in cardiac dysfunction [5] . It is believed that the use of proteomic analysis to investigate heart disease should result in the generation of new diagnostic and therapeutic markers [6] . To search for cardiac specific biomarkers, the analysis of cardiac tissue remains necessary [7] and experimental animal models allow to study serial changes in cardiac tissue proteins over time, and relate these changes to RHF and cardiac dysfunction. Our objective was thus to find changes in protein expression, which are specifically linked to right ventricular remodeling in RHF. For this purpose, we performed differential proteomic analysis of RV in rats in which RHF was induced either by monocrotaline (MCT) [8] or chronic hypoxia [9] as compared to RV from normal rats. The chronically hypoxic animal model, one of the most commonly used animal models, is obtained by exposure of rats to chronic-hypoxic conditions (four weeks) under hypobaric conditions (keeping animals in a chamber with barometric pressure adjusted to 0.5 atmosphere) [10, 11] . These conditions induce a progressive increase in both the mean pulmonary artery pressure (pap) and the Fulton index (the ratio of right ventricle to left ventricle plus septum weight) from 12-15 to 30-35 mm Hg and 0.25% to 0.5%, respectively. An increase in the pap and right ventricle hypertrophy are maximal at three to four weeks of hypoxia [10, 11] . The other model is the MCT-treated rat. A single administration of MCT (generally a subcutaneous injection at the concentration of 60 mg/kg) is sufficient to induce PAH [12] [13] [14] . The initial injuries result in endothelial degeneration or hyperplasia, hypertrophy of medial smooth muscle, and adventitial edema [15] . These changes result in the augmentation of vascular resistance and the pressure overload of the right ventricle. MCT induced a higher increase in the pap mm Hg) than hypoxia [16] . MCT-induced pulmonary hypertension (MCT-PAH) and cardiac dystrophy are irreversible [16] . MCT-PAH is also accompanied by a massive mononuclear infiltration into the perivascular regions of arterioles and muscular arteries. From this point of view (i.e., the inflammatory process), the MCT model is considered as a standard model for idiopathic PAH (IPAH) [17] . All the experiments through the paper were un-pooled experiments to make sure that we avoid any bias effect due to the use of two models. We observed that the RHF is associated with the modulation of numerous gene and proteins in the RV. Importantly, our data provide strong evidence of an ubiquitin-proteasome system (UPS) dysfunction in RHF. Our study offers new insight into the complex integration of UPS expression and activities within metabolic network that are linked to changes in pathophysiological state of RHF.
Materials and Methods

Heart Models
All animal experiments, euthanasia and tissue collection were performed according to protocols approved by the Institutional Animal Care and Use Committee of Bordeaux University. To induce Right Heart Failure (RHF) in rats, six week-old male Wistar rats received a single subcutaneous injection of 60mg/kg (body weight) monocrotaline (MCT), while control animals were treated with an equal volume of vehicle. In the other group, for induction of RHF by chronic hypoxia, six week-old male Wistar rats were placed in a ventilated chamber system with an inspired O2 fraction (FiO2) of 0.10, while control animals were maintained under normoxia. All animals were euthanized on day 28, when they showed accelerated breathing, lethargy, and ruffled fur.
Tissue Sample
Rats were euthanized after intraperitoneal injection with 50 mg/kg of ketamine and 10 mg/kg of xylazine. Hearts were rapidly excised and removed of any blood cells. The right ventricle (RV) and left ventricle (LV) plus septum (LV+S) were dissected and snap-frozen in liquid nitrogen. Samples were stored at -80°C until further use. Right ventricular hypertrophy was confirmed by the ratio of the right ventricular weight to body weight and compared to the left ventricular weight to body weight ratio.
Measurement of Fulton Index
The Fulton index was measured as the ratio of the RV divided by LV+S weights.
Hemodynamic Studies
Right Ventricular Pressure (RVP) was measured using the technique as previously described by van Suylen RJ et al. [18] . Mean RVP was calculated by digital integration.
Right ventricle protein identification by LC-MS/MS
RV proteins were extracted from each tissue sample, six animals per condition, by homogenization and solubilization in 30 mmol/L Tris-HCl pH 8.0, 150 mmol/L NaCl, 1.5% CHAPS and protease inhibitor cocktail (Sigma). The lysates were clarified by centrifugation at 435000 X g max for 30 min at 4°C. Protein concentrations were determined according to the Bradford assay. Isolated RV proteins were solubilized in Laemmli buffer, and subjected to SDS-PAGE gel to evaluate concentration and for cleaning purpose. After entering the resolving gel, separation was stopped. Following a colloidal blue staining, bands were cut out from the SDS-PAGE gel and subsequently cut in 1 mm x 1 mm gel pieces. Gel pieces were destained in 25 mmol/L ammonium bicarbonate 50%, rinsed twice in ultrapure water and shrunk in acetonitrile (ACN) for 10 min. After ACN removal, gel pieces were dried at room MS/MS spectra were acquired using a 3-m/z unit ion isolation window and normalized collision energy of 35. Mono-charged ions and unassigned charge-state ions were rejected from fragmentation. Dynamic exclusion duration was set to 30s.
Database search and results processing
Data were searched by SEQUEST through Proteome Discoverer 1.3 (Thermo Fisher Scientific Inc.) against a subset of the 2012.01 version of UniProt database restricted to Rattus norvegicus Reference Proteome Set (35,598 entries). Spectra from peptides higher than 5000 Da or lower than 350 Da were rejected. The search parameters were as follows: mass accuracy of the mono-isotopic peptide precursor and peptide fragments was set to 10 ppm and 0.8 Da respectively. Only b-and y-ions were considered for mass calculation. Oxidation of methionines (+16 Da) was considered as variable modification. Two missed trypsin cleavages were allowed. Peptide validation was performed using Percolator algorithm [19] and only "high confidence" peptides were retained corresponding to a 1% False Positive Rate at peptide level. Noticeably, only non-conflicting features and unique peptides were considered for calculation at protein level. Quantitative data were considered for proteins quantified by a minimum of 2 peptides.
Label-Free Quantitative Data Analysis
Protein isolation and western blotting from ventricular tissue
Right and left ventricle protein extracts were extracted as described above (Right ventricle protein identification by LC-MS/MS), and then processed for immunoblot analysis as previously described [20] . Quantification was performed using ImageJ software. Results were normalized to the anti-Gapdh protein and are presented as fold change compared with control rat, which was set to one.
Analysis of mRNAs
Total mRNA was extracted from right and left rat ventricles using Trizol (Invitrogen) extraction procedure as previously described [20] . RNA concentration, purity and quality were determined using the Nanodrop (Thermo Fisher scientific). For cDNA synthesis, reagents and incubation steps were applied according to the manufacture's protocol using Superscript III (Invitrogen). Real-time PCR was used for relative quantification of each gene using Gapdh as the reference gene. Quantification was performed by using ImageJ software.
Results were normalized to the invariant transcript Gapdh protein and are presented as fold change compared with control rat, which was set to one. Primers sequences are shown in Supplemental Table S1.
Determination of overall proteosomal activities
Experiments were performed as we previously described [21] . Briefly, heart tissues were kept [22] , the assay was therefore performed in presence of ATP to measure the overall proteasome activity which requires ATP [23, 24] . Therefore we have used 1mM
ATP as previously described [23, 24] . All assays were performed in triplicate. The incubation took place at 37°C for 60 min in a 96-well plate. 
Statistical analysis
Data are presented as standard error of the mean ± SEM for all studies. Statistical differences between groups were analyzed using a Student's t-test with GraphPad Prism 4 software. A P value of 0.05 or lower was considered significant. All experiments were designed with matched control conditions to enable statistical comparison.
Antibodies and reagents
The sources of the primary antibodies used in these studies were as follows: Anti-Proteasome Subunit alpha-5 (PSMA5) (ThermoScientific), anti-Proteasome Subunit beta-5 (PSMB5) (Enzo, Life Sciences), anti-ubiquitin (Sigma-Aldrich) and anti-Gapdh (Chemicon).
Results
Animal and heart analysis
To assess the global protein alteration pattern during Right Heart Failure (RHF), two rats model of RHF were generated: rats under hypoxia conditions and rats injected with monocrotaline (MCT). Representative pictures of the heart from the different animals (control as compared to hypoxia or MCT conditions) displayed an increase of heart morphological size. No statistical differences were observed between MCT and chronic hypoxia controls animals (Figure Supp. 3A-C).Both conditions either MCT or chronic hypoxia induced RHF therefore from now and latter on, we will group both conditions under RHF animals ( Figure   1A ). We next evaluate the heart to body weight ratio ( Figure 1B , E and H). The right ventricular weight/body ratio was significantly increased in RHF animals as compared to control animals (control 0.55 ± 0.031mg/g vs RHF 1.16 ± 0.074mg/g, Figure 1H ), while the left ventricular weight/body weight ratio was unaltered (control 2.02 ± 0.134mg/g vs heart failure 2.11 ± 0.117mg/g, Figure 1I ), indicating that conditions with MCT or chronic hypoxia resulted in pronounced myocardial hypertrophy, which was restricted to the Right Ventricle (RV). As previously reported [8, 9] , RHF animals present a significant increased of the Fulton index (control 0.28 ± 0.007mg/g vs heart failure 0.54 ± 0.004mg/g, Figure 1J ) as compared to control rats.
Quantitative analysis of RV proteins associated with RHF
To specifically screen for expressional changes in RV from RHF rats, we isolated RV and performed a LC-MS/MS analysis with RV from six un-pooled RHF animals (three MCT and three chronic hypoxia) and six rat controls (see Materials and Methods).
By identifying features across all LC-MS/MS runs, analysis in Progenesis LC-MS 4.0 allowed relative quantification of all peptides identified. The label-free quantitation of all proteins identified is presented in Supplemental Table 4 . We have thus conducted an exhaustive study where we have carefully compared un-pooled control animals to un-pooled MCT and unpooled control normoxia to un-pooled hypoxia animals (Supplemental Table S4 ) to finally conserve the common protein changes that could explain right heart failure. Per proteins, a minimum of 2 peptides, were quantified. Proteins displaying changes in intensity, which were significantly associated with RHF, were detected by ANOVA test based on the protein level, and p value under <0.05 were considered as biological relevant. Our quantitative proteomics resulted in the confident detection of 126 proteins differentially expressed with either an increased or decreased intensity in RHF rats as compared to normal rats. A listing of these 126 proteins was provided in Supplemental Table 2 and 3. Fifty six RV proteins were upregulated (Supplemental Table S2 ) and seventy RV proteins were down-regulated (Supplemental Table S3 ) in RHF-rats.
Classification of the RV proteins displaying RHF-related changes
A graphical presentation of the cellular components, biological processes and molecular functions affected in RHF as predicted by analysis with the PANTHER program (http://www.pantherdb.org/) is displayed in Figure 2 .
The majority of changes were associated with cytoskeleton proteins (Figure 2A As expected, the majority of changes in molecular functions were associated with structural constituent of cytoskeleton, motor activity, structural molecule activity, cytoskeleton protein binding and microtubule binding ( Figure 2C -left panel) , which are typical sign of hypertrophy. The majority of the proteins involved in these molecular functions displayed higher levels in RHF rats compared to the control group ( Figure 2C -right panel) . Surprisingly, the second group of altered molecular functions was represented by proteins of the peptidase activity ( Figure 2C -left panel) . Thirteen out of fourteen proteins involved in the peptidase activity displayed lower levels in RHF rats compared to the control group ( Figure 2C -right panel) . Moreover, another group of altered proteins was represented, the proteins involved in peptidase inhibitor activity. Interestingly, a deep analysis of the proteins belonging to peptidase molecular function showed eight proteins. These eight proteins Psma1, Psma2, Psma4, Psma5, Psma7, Psmb4, Psmb5 and Psmb6, belong to the proteasome complex and were dramatically decreased (Table 1 ). In contrast, within the group of five peptidase inhibitors, three are up-regulated and two of them have for function to be protease inhibitors. These two proteins, Cast and Serpina3n, were expressed at very high levels in RHF animals ( Table 1 ). In addition, all the proteasome proteins identified in this study, displayed drastically low levels in RHF animals (Supplemental Table S3, and Table 1 ).
Since the proteasome complex seems to be differentially regulated in RHF, we therefore focus on the proteasome for further analysis.
Validation of proteasome proteomic data by protein expression profiles
With the use of Western blot [20] , the down-regulation of two representative proteasome proteins, Psma5 and Psmb5, were assessed. RV and LV proteins were extracted from six RHF animals (three MCT and three chronic hypoxia) as compared to six rat controls (see Materials and Methods). The mean of six different control and six different RHF rats, as well as the standard deviation and p-values, was determined for both the RV and Left Ventricle (LV). These data were summarized in histogram format in Figure 3 . The images of the samples used for histogram quantification are presented in Supplemental Figure 2 . As compared to Gapdh, a statistically significant decrease for Psma5 ( Figure 3A ) and Psmb5 ( Figure 3B ) was detected specifically in the RV from RHF rats. Thus, the trend towards down-regulation for theses two proteasome proteins confirmed and validated the directionality revealed by our proteomic quantitative analysis (Table 1 and Supplemental   Table S3 ).
Validation of proteasome proteomic data by gene expression profiles.
The proteasome consists of a 20S proteasome core and two 19S regulatory subunits [25] . The 20S proteasome core is composed of 28 subunits that are arranged in four stacked rings, resulting in a barrel-shaped structure. The two end rings are each formed by seven α-subunits, and the two central rings are each formed by seven β-subunits [25] . Our results obtained above on the proteasome proteins show proteins from α-and β-subunits, therefore the subsequent analyses were only focused on α-and β-subunits of proteasome differentially regulated (Table 1) . To validate the proteomic dataset but also to evaluate the effect of inducing RHF on both ventricles (RV and LV), we investigated first to measure the genomic expression level of these proteins in the RV ( Figure 4A ) and LV ( Figure 4B ) from rats with RHF as compared to control rats. We extracted total mRNA of RV and LV from six RHF animals (three MCT and three chronic hypoxia) as compared to six rat controls (see Materials and Methods). RV and LV mRNA expressions of α-and β-subunits of proteasome normalized to Gapdh are summarized in Figure 4 . The level of GAPDH was unaffected during RHF ( Figure 4 E-F) . Psma1, Psma2, Psma4, Psma5 and Psma7 (α-subunits) transcript levels were all statistically decreased in the RV of RHF compared to control rats ( Figure 4A , black boxes vs white boxes). In contrast, these α-subunits were not statistically regulated in LV in RHF rats as compared to control rats ( Figure 4B , black boxes vs white boxes). We also investigated the expressions of β-subunits genes: Psmb4, Psmb5 and Psmb6. In the RV, these β-subunits mRNAs were significantly decreased in RHF rats compared to control rats ( Figure 4A , black boxes vs white boxes), whereas in the LV the mRNA levels did not differ significantly between RHF and control rats ( Figure 4B , black boxes vs white boxes).
Interestingly, Calpastatin (Cast) and Serine protease inhibitor A3N (Serpina3n), which are two protease inhibitors were significantly up-regulated in RHF rats (Table 1) . Messenger RNA content of Cast and Serpina3n were strongly increased in RV of RHF rats compared to control rats ( Figure 4C , black boxes vs white boxes), whereas their LV transcript levels were unchanged in RHF and control rats ( Figure 4D , black boxes vs white boxes).
Comparison of poly-ubiquitinated proteins profiles
A direct consequence of the down-regulation of both α-and β-subunits of proteasome mRNA ( Figure 4A and B) and proteins (Table 1 and Figure 3 ) could be a modification of polyubiquitinated proteins patterns. Therefore, we next evaluated the amount of poly-ubiquitinated proteins in the LV and RV homogenates of normal and RHF rats. We isolated RV and LV proteins from six RHF animals (three MCT and three chronic hypoxia) as compared to six rat controls (see Materials and Methods). We found that the intensity of high-molecular weight bands was increased in the RV of the RHF rats compared to control rats ( Figure 5A and B), whereas no major differences in the ubiquitin signals was observed in the LV between RHF and control rat ( Figure 5A and C). These results confirmed that a specific modification of the ubiquitination pattern occurs in the RV of RHF animals.
Proteasome activities in RHF
Proteasome inhibition is known to lead to the accumulation of ubiquitinated proteins.
Thus, based on the specific accumulation of ubiquitinated proteins shown in Figure 5 , and the clear down-regulation of both α-and β-subunits of proteasome at the mRNA ( Figure 4 ) and proteins levels (Table 1 and Figure 3 ) in the RV, we hypothesize that the proteasome activities must be altered in RHF. To determine whether this drastic decreased in protein abundance results in decreased proteasome catalytic activity, we used a fluorescent assay to measure the three activities. Figure Supplemental 1A -C shows the linearity of this assay in a ventricle extract from control animals based on the amount of protein added.
Thus, we have next measured the three different proteasome activities, caspase-like, trypsin-like and chymotrypsin-like activities of RV in RHF and control rats ( Figure 6 ). We isolated RV and LV tissues from six RHF animals (three MCT and three chronic hypoxia) as compared to six rat controls (see Materials and Methods). All proteasome activities were distinguished from background proteolitic activities with a proteasome inhibitor as detailed in Materials and Methods. The trypsin activity was decreased by 75% after addition to the assay buffer of the inhibitor (Figure Supp. 1D) . The chymotrypsin activity was decreased by 92% after addition to the assay buffer of the inhibitor (Figure Supp. 1E ) and caspase activity was decreased by 89% ( Figure Supp. 1F) . To further assess the contribution of nonproteasomal enzymes, we have used a highly specific inhibitor of proteasomes, epoxomicin. The most widely used proteasome inhibitor MG132 is not suitable for these purposes because it can also inhibits lysosomal enzymes [24, 26, 27] . Using epoxomicin, we found that the chymotrypsin activity was decreased by 76% (bar graph dark grey) after addition of the inhibitor whereas caspase-like activity was not significantly affected (bar graph light grey) ( Figure Supp. 1G) .
Interestingly, proteasome activities were differentially regulated (Figure 6 ), trypsin-like activity was unaltered ( Figure 6A , black boxes vs white boxes), whereas chymotrypsin and caspase-like activities, were significatively decreased around 60% in RHF compared to the activities in control rats ( Figure 6B and C, black boxes vs white boxes).
Recently, Kim et al., have shown that a daily administration of Bortezomib after induction of
RHF suppressed substantially RHF [28] . To investigate how a proteasome inhibitor could alleviate RHF after RHF induction, we have followed the proteasome activity during the . Table S5 and Figure 7D ).
Since the proteasome inhibitor (Bortezomib) after induction of RHF has been shown to be beneficial to treat RHF, we hypothesize that during the development of RHF, the proteasome activity increase to reach a maximum activation, and then the activity decreased below the basal level to adapt the heart to its morphological changes. Thus, we have next measured the changes in proteasome activity in response to pressure overload induced by hypoxia following four weeks. We observed that after one week both activities chymotrypsin and caspase increased ( Figure 7E-F) to then drop down under basal levels.
Discussion
Until recently, right heart disease has been relatively understudied and underappreciated. A recent report using in-depth quantitative proteomics have investigated the differential proteome of isolated mouse right and left ventricle [29] . Interestingly they found very subtle change between LV and RV, suggesting that changes in protein expression due to HF could be specifically linked to remodeling of the ventricle. In order to dissect differences particular to RHF hypertrophy, the aim of this study was to search for protein that were differentially expressed. Proteomic expression profiling of RV in RHF had identified 126 differential protein expressions (Supplemental Tables S2 and S3 ). Among the proteins that are up-regulated in RHF, we found several proteins already reported at the RNA level in RHF mice model [30] such as tropomyosin 1, myosin heavy polypeptide 9, Synpo protein, Reticulon-4, Neural cell adhesion molecule 1. However few reports in the literature have look at down-regulated proteins rather than up-regulated proteins. Interestingly, many proteasome subunit α-and β-proteins quantified in our study were found highly depressed in the RV of RHF rats (Table 1 ). The cardiac proteasome contains a variable proteasome complex consisting of different proportions of β-subunits [31] . Alternations in proteasome subunit composition affect overall proteasome proteolytic activity, which, in turn, may alter the specificity and selectivity of the proteasome for various substrates under certain conditions. The proteasome subunit α-and β-proteins, Psma1, Psma2, Psma4, Psma5, Psma7, Psmb4, Psmb5 and Psmb6 show low expression levels in RHF as compared to the control group (Table 1) . Interestingly, the increased expression of protease inhibitors (Figure 4 ) in RHF let us to suggest that the balance between proteasome components and protease inhibitors is specifically altered in the RV of RHF. Indeed, Serpina3n belongs to the Serpin family of protease inhibitors. Some of them such as Plasminogen activator inhibitor type-1 (PAI-1) [32] and type-2 (PAI-2) [33] have been shown to interact with proteasome and affect its activity, suggesting that an increase in the expression of protease inhibitors could reflect and confirm a decrease in proteasome activity. By Western blot, the down-regulation of two representative proteins, Psma5 and Psmb5, was confirmed (Figure 3) . Thus, the trend towards downregulation for theses two proteasome proteins confirmed the directionality revealed by our proteomic quantitative analysis. Psma1, Psma2, Psma4, Psma5 and Psma7 (α-subunits) transcript levels were all statistically decreased specifically in the RV of RHF compared to control rats ( Figure 4A ). In contrast, as expected, these α-subunits were not statistically regulated in LV in RHF rats as compared to control rats ( Figure 4B ). As well, in the RV, the β-subunits mRNAs (Psmb4, Psmb5 and Psmb6) were also significantly decreased in RHF rats compared to control rats ( Figure 4A ), whereas in the LV the mRNA levels did not differ significantly between RHF and control rats ( Figure 4B ). In LHF, this type of alteration has also been reported that the transcript levels of some of the α-and β-subunits of the 20S proteasome were downregulated in failing human hearts compared with non-failing hearts [34, 35] , however the pattern of alteration such as the type of subunits seems to be slightly different in the RVH as compared to the LHF. This is consistent with the physiological requirement of the RV as compared to the LV. In a non-disease state, the LV encounters the relatively high pressures of systemic circulation, which requires the formation of a thick myocardium, while RV has only to cope with the low pressure of pulmonary circulation and develops a thin wall. Due to their anatomic differences, any increase in pressure will have a much more severe impact on the RV than on the LV. Comparative microarray based transcriptome analysis of RV and LV remodeling identified distinct responses to pressureinduced hypertrophy [30] .
The alterated proteasome proteins identified belong to the ubiquitin-proteasome system (UPS). The UPS is the major non-lysosomal pathway for intracellular degradation of proteins and plays a major role in regulating many cellular processes. The key components of the UPS are the 26S proteasome and ubiquitin [36] .The role of ubiquitin in the UPS is to act as a tag for the proteasome to identify how the protein targeted for proteolytic degradation is destroyed. It has been reported, that during the transition of hypertrophy to LHF in patients, there was an increased level of ubiquitination during hypertrophy followed by increase upon the onset of heart failure [37] [38] . In our model RHF, we found that the intensity of several bands of poly-ubiquitinated proteins was only increased in the RV of the RHF rats compared with control rats ( Figure 5A and B), whereas no major differences in the ubiquitin signals was observed in the LV between RHF and control rats ( Figure 5A and C) .
Here, we report by immunoblot analysis an accumulation of ubiquitinated proteins ( Figure 5) and also a down-regulation of both α-and β-subunits of proteasome at the mRNA ( Figure 4) and proteins levels (Table 1 and Figure 3 ) specifically in RV from RHF rats. Altogether, these results suggest impairment of RV proteasomal activity in RHF rats. The vast majority of proteins in mammalian cells is degraded by 26S proteasomes [39] . The 26S enzyme consists of the 20S proteasome and one or two 19S regulatory complexes [40] . The 20 S proteasome is composed of two outer α-and two inner β-rings [40] . Each ring contains seven different subunits, and each β-ring contains three proteolytic sites, which differ in their substrate specificities. The "chymotrypsin-like" site cleaves peptide bonds preferentially after hydrophobic residues; the "trypsin-like" site cuts mainly after basic residues, and the third site "caspase-like" cuts preferentially after acidic residues [41] . It has been reported that the association of 20 S proteasomes with the 19 S regulatory complexes to form 26 S proteasomes leads to much higher rates of peptide hydrolysis [42] and confers the ability to degrade ubiquitinated proteins as well as certain non-ubiquitinated polypeptides [43] . Thus the decrease of β subunits proteins (Figure 4 ) and the increased in ubiquitinated proteins ( Figure   5 ) correlates with the effect on 26S proteasome activities ( Figure 6 ). Recently, a growing body of evidence suggests that alteration of proteasome-mediated protein degradation also contributes to the initiation and/or progression of cardiac diseases [44] [45] [46] . Inhibition of the proteasome has been shown to impair the heart function, as indicated by the use of bortezomib, a FDA-approved chemotherapeutic anti-cancer medication, which increases the occurrences of heart failure [47] . It has been also demonstrated that bortezomib induced complications in the stressed mouse heart [48] . Kim et al., have shown that a daily administration of Bortezomib after induction of RHF suppressed substantially RHF [28] .
Indeed, in both models hypoxia-and MCT-induced animals Bortezomib inhibits RV hypertrophy and vascular remodeling. This type of inhibitors already used clinically for the treatment of multiple myelanoma, could therefore be beneficial in the development of RHF.
However, other studies in rat, murine, and porcine models indicate that proteasome inhibition could be cardioprotective [49] . The effects of proteasome inhibition during myocardial ischaemia on cardiac function have been controversial, as both beneficial and deleterious effects have been reported. In heart failure with proteasome dysfunction, bortezomib has a detrimental effect. In contrast, during early remodeling and left ventricular hypertrophy, Hedhli et al. [49] as well as Drews et al. [50] observed increased proteasome activities, showing that under these circumstances, Bortezomib was cardioprotective. Thus, the proteasome activities in cardiac disease remain a subject of debate and the specific molecular components, function, and regulation of the cardiac proteasome still remains largely unknown. Analyses of human biopsies of failing hearts support the concept that defective protein degradation contributes to heart failure. However, although most studies are congruent in showing high total levels of ubiquitinated proteins in failing hearts [51] , it remains unclear whether this is attributable to impaired proteasome function. Some reports show that the levels and activity of the proteasome are unchanged in failing hearts [52] . In contrast, other reports show that proteasome activity is impaired in failing hearts, possibly as a result of oxidative modifications on proteasome subunits [53] .
Here, we correlate the time-frame of RHF development to proteasome activity and found that proteasome activity increase and then drop down below basal level, these results might explained the differences between studies based on the day for which proteasome activity was measured. Based on the time-course of proteasome activity during the development of RHF, we believe that caution should be taken before comparing studies since the activity has two phases, first an increase followed by a drastic decrease at the end-stage of RHF. This model is consistent with Tsukamoto et al. paper in mouse model [54] . Thus, the proteasome activities in cardiac disease remain a subject of debate and the specific molecular components, function, and regulation of the cardiac proteasome still remain largely unknown. Several experimental studies have demonstrated the contribution of UPS dysfunction to the pathogenesis of LHF disease, however, there is no report investigating the role of UPS in the pathogenesis of RHF, until recently. In parallel to our study, Rajagopalan et al. have reported that proteasome activity is decreased in another model of RHF also suggesting that UPS dysfunction contributes to RHF [55] . It has been demonstrated previously that ubiquitinated proteins are accumulated when proteasome is deactivated and also that the inhibition of proteasome chymotrypsin-like activity was linked to an accumulation of ubiquitinated proteins [56] . Thus, depression of these two proteasome activities found in our study ( Figure 6 and 7) correlates with the accumulation of ubiquitinated proteins observed in Figure 5 .
Conclusion
In summary, our study demonstrates an impairment of UPS in the RHF disease with a decrease of transcript and protein levels of some α-and β-subunits of proteasome, an accumulation of ubiquitinated proteins and a specific decrease of the caspase-like and chymotrysin-like proteolitic activities in the RV. In conclusion, we demonstrate a potential role of impairment of ubiquitin-proteasome system in the development of RHF. However, it remains unclear whether the UPS is impaired as a byproduct of the pathogenesis or in fact contributes to the development of the pathogenesis. Future work in human tissue is necessary to define the precise mechanisms for proteasome dysfunction and to establish a causal link to RHF. Table   Table A C. The mean Fulton index is measured as described in the Methods, in rats under chronic hypoxia and, in rats treated with monocrotaline. (n = 3, mean ± SEM). Table S1 . Primers used for PCR verification (5' -3').
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